Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Wednesday, March 26, 2025 · 797,235,343 Articles · 3+ Million Readers

Amebiasis Global Market Report 2025: Comprehensive Insights, Trends, And Forecasts

The Business Research Company

The Business Research Company

Amebiasis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

The amebiasis market size is expected to see strong growth in the next few years. It will grow to $1.14 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%.”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Are You Ready For Significant Market Expansion In The Coming Years?

The amebiasis market size has shown remarkable growth in recent years. It is projected to rise from $0.82 billion in 2024 to $0.88 billion in 2025, marking a compound annual growth rate CAGR of 6.9%. This robust growth in the historic period can be ascribed to various factors, such as the escalating incidence of amoebic infections in tropical regions, unhygienic sanitation practices in developing nations, an increase in international travel, particularly to endemic regions, greater awareness about the disease, and scarce access to clean drinking water in rural areas.

What Factors Are Fueling The Growth Of The Amebiasis Market In The Forecast Period?

The amebiasis market size is predicted to witness substantial growth in the upcoming years, bolstered by various factors including rising immune-compromised populations, government initiatives to enhance sanitation and healthcare infrastructure, growing investments in research for novel treatments, emerging health initiatives to battle parasitic diseases, and the proliferating demand for effective oral medications. This market is slated to expand to $1.14 billion in 2029 at a compound annual growth rate CAGR of 6.6%.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp

What Are The Ongoing Trends Enhancing The Growth Of The Amebiasis Market?

Major trends in the forecast period encompass the growing adoption of combination therapies, development of vaccines, advancements in drug delivery systems, improvements in pharmaceutical research, and the inception of ground-breaking antiprotozoal drugs.

How Are Increasing Cases Of Parasitic Infections Shaping The Market?

The escalating cases of parasitic infections are set to energize the growth of the amebiasis market. Parasitic infections, induced by parasites like protozoa, helminths, or ectoparasites, contribute to diseases by deriving nutrients at the host's expense. A wide range of factors such as enhanced travel, climate change, poor sanitation, and the rise of drug resistance collectively promotes the spread and persistence of these infections. In January 2024, the Animal and Plant Health Agency, a UK-based government agency, logged a total of 1,071 diagnoses of Parasitic Gastroenteritis PGE in 2022.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report

How Is The Increasing Prevalence Of Poor Sanitation Affecting The Amebiasis Market?

Poor sanitation, characterized by the lack of access to clean water, adequate sewage disposal, and hygienic facilities is instrumental in propagating diseases. In July 2023, according to the United Nations Water, an astonishing 2 billion people still lacked access to basic hygiene services, while 3.5 billion were bereft of safely managed sanitation. This represents a significant growth driver for the amebiasis market.

Who Are The Significant Players Operative In The Amebiasis Market?

Prominent companies in the amebiasis market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cepheid Inc., Mission Pharmacal Company, Profounda Inc., Zydus Lifesciences Limited.

What Are The Emerging Trends In The Amebiasis Market?

Larger players are zeroing in on developing advanced solutions including ready-to-use oral liquid metronidazole forms to enhance patient compliance and treatment efficacy.

How Is The Amebiasis Market Segmented?

1 By Type: Metronidazole, Paromomycin, Tinidazole
2 By Route of Administration: Oral, Intravenous
3 By Application: Hospital, Pharmacy

Moreover, it offers several subsegments such as:
1 By Metronidazole: Oral Metronidazole, Intravenous Metronidazole, Combination Therapy with Metronidazole
2 By Paromomycin: Oral Paromomycin, Paromomycin in Combination with Other Drugs
3 By Tinidazole: Oral Tinidazole, Tinidazole for Severe Infections

How Is The Global Amebiasis Market Distributed Regionally?

North America topped the chart in the amebiasis market in 2024. Asia-Pacific has emerged as the fastest-growing region during the forecast period. The report presents an extensive, region-wise analysis, covering Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse For More Similar Reports-
Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Antibiotic Free Meat Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

Inhaled Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report


About The Business Research Company:

The Business Research Company boasts a repository of over 15000+ reports spanning 27 industries and 60+ geographies. It prides itself on comprehensive, data-rich research and insights. Armed with 1.5 million datasets, in-depth secondary research, and unique insights from industry leaders, it provides valuable data that helps you to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: info@tbrc.info

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire

Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release